Contemporary outcome measures in acute stroke research: choice of primary outcome measure.
about
Interventions for deliberately altering blood pressure in acute strokeDo stroke models model stroke?Pharyngeal Electrical Stimulation for Treatment of Poststroke Dysphagia: Individual Patient Data Meta-Analysis of Randomised Controlled TrialsMore outcomes than trials: a call for consistent data collection across stroke rehabilitation trialsAcute Stroke Imaging Research Roadmap II.Time for a step change? Improving the efficiency, relevance, reliability, validity and transparency of aphasia rehabilitation research through core outcome measures, a common data set and improved reporting criteria.Performance characteristics of methods for quantifying spontaneous intracerebral haemorrhage: data from the Efficacy of Nitric Oxide in Stroke (ENOS) trial.Intravenous transplantation of mesenchymal stem cells preconditioned with early phase stroke serum: current evidence and study protocol for a randomized trial.Reduced mortality and severe disability rates in the SENTIS trial.Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial.Representation of people with aphasia in randomized controlled trials of acute stroke interventions.The stroke oxygen pilot study: a randomized controlled trial of the effects of routine oxygen supplementation early after acute stroke--effect on key outcomes at six monthsPlasma midregional pro-adrenomedullin improves prediction of functional outcome in ischemic stroke.Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial.Effect of pre-stroke statin use on stroke severity and early functional recovery: a retrospective cohort studyDerivation and Validation of a Modified Short Form of the Stroke Impact ScaleIntensive versus Guideline Blood Pressure and Lipid Lowering in Patients with Previous Stroke: Main Results from the Pilot 'Prevention of Decline in Cognition after Stroke Trial' (PODCAST) Randomised Controlled Trial.Evolution of ischemic damage and behavioural deficit over 6 months after MCAo in the rat: Selecting the optimal outcomes and statistical power for multi-centre preclinical trialsAn International Standard Set of Patient-Centered Outcome Measures After Stroke.Robotic measurement of arm movements after stroke establishes biomarkers of motor recovery.Analysis of the Modified Rankin Scale in Randomised Controlled Trials of Acute Ischaemic Stroke: A Systematic Review.Continuing versus Stopping Prestroke Antihypertensive Therapy in Acute Intracerebral Hemorrhage: A Subgroup Analysis of the Efficacy of Nitric Oxide in Stroke Trial.Early Versus Late Assessment of Stroke Outcome.Progesterone treatment for experimental stroke: an individual animal meta-analysis.Stroke statistics in Korea: part I. Epidemiology and risk factors: a report from the korean stroke society and clinical research center for strokeRegression analysis of ordinal stroke clinical trial outcomes: an application to the NINDS t-PA trial.Comparative Effectiveness of Prestroke Aspirin on Stroke Severity and Outcome.Self-perceived health status following aneurysmal subarachnoid haemorrhage: a cohort study.The spectrum of translational stroke research.Interdependence of stroke outcome scales: reliable estimates from the Virtual International Stroke Trials Archive (VISTA).SAHIT Investigators--on the outcome of some subarachnoid hemorrhage clinical trials.Mid-Term Blood Pressure Variability Is Associated With Clinical Outcome After Ischemic Stroke.Aphasia and Dysarthria in Acute Stroke: Recovery and Functional Outcome.Ambulance-delivered transdermal glyceryl trinitrate versus sham for ultra-acute stroke: Rationale, design and protocol for the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2) trial (ISRCTN26986053).Added Value of Patient-Reported Outcome Measures in Stroke Clinical Practice.Post-stroke dysphagia: A review and design considerations for future trials.Baseline characteristics of the 3096 patients recruited into the 'Triple Antiplatelets for Reducing Dependency after Ischemic Stroke' trial.Pharmacological therapies in post stroke recovery: recommendations for future clinical trials.A standardized approach to the Fugl-Meyer assessment and its implications for clinical trials.Simplified modified Rankin Scale questionnaire correlates with stroke severity.
P2860
Q24193073-BA2A7A9D-E52C-4935-962C-C4E4BC1D5A88Q24288828-8A93D762-6C0B-4E00-B924-CDC9CEEBE690Q26774522-107B15DF-76D9-4712-B869-1EF969284513Q27009182-4B852FEE-8ED4-4999-A4D4-E42ED55A3FA1Q30411115-4D35E531-3267-48CE-AD59-2438E978D1A9Q30855760-1753E5B7-9610-47D4-9CB4-A3C3CFDFDD1AQ30883837-5959CF62-CDBF-451E-959F-24536B62A365Q33592708-642FF247-A78B-4ABE-ADAF-6F3335689D59Q34143609-12508019-8F45-4435-9896-DEE2931AB4A8Q34531759-74277539-21AE-4D5F-BECA-262DC7934C8CQ34626374-DBA87334-C0BC-4459-A4FF-B7DA6B56E850Q34765493-E34001C3-22F6-40CD-825E-0CAF5753EBF5Q34873180-FF21F87B-32B5-4FAC-B19A-BDBA90E1CAC2Q35129507-15117CC2-CF42-4D4E-B184-07180B95DBF7Q35725087-401E87AC-10F9-406F-B4A6-C3EE25FBE398Q36025010-C719B012-A1F5-46F2-8586-5B098DB82EBEQ36251159-9AC22FFC-7827-4EAB-9207-DED3473A4586Q36275582-46738E27-AAC6-439E-8891-4C68772D46B7Q36398802-4BDD6AAB-AB88-480A-A0FC-85A10B2DD7FAQ36399645-539ED92F-F228-4256-BF51-3BD7F21FA2C0Q36759649-51BABDD4-4E75-45F8-916B-EACA236A7314Q36852813-883DE928-1539-409A-B769-276DB172DBEAQ37078586-84682AE3-AF97-4694-84C6-3F729BB32BE9Q37150327-A3D0066B-FF7F-4FE9-B09C-398C57F31110Q37189367-DAF9E551-565D-41DC-870B-EFFF58C214CDQ37297296-306BA6E4-8E5D-416B-AAFB-3B7E9848CA06Q37345715-5680479D-5A6E-42FE-A9D0-5A3794A02BCCQ37704426-B99F8B2A-4E71-46AD-9F75-00A0BAE02DCBQ38099697-E7007D9E-DAE6-4293-8640-B10183A9E60EQ38160949-568EBC78-2404-4A2D-85AC-06EF230A742DQ38169991-CFB07AD8-689C-4B7B-894F-BA48F08F6DB7Q38375261-C9503D2F-8D38-40DF-B6B4-DEFA33BF3B39Q38387110-79BFAFC5-88F5-404F-8869-460B3E00C121Q38649591-CAF1316B-D852-4323-9E2C-96D539BBA3E0Q38667236-D837DC7C-C823-4B87-9A80-4F5F6C071021Q38785886-406614D6-2D0F-4DBD-AEB8-E14ED4103347Q38896828-79BD1FFA-81FB-418D-88B8-B74705AC2164Q39316641-45208FCB-19E0-4A4A-8CE0-3682D034C72BQ39401190-9B128BF6-73E7-482D-A4FD-D6AF1BE29A86Q39466933-D45B2077-51FE-47A0-AF13-B5F6C5ECE0A7
P2860
Contemporary outcome measures in acute stroke research: choice of primary outcome measure.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Contemporary outcome measures ...... ce of primary outcome measure.
@en
Contemporary outcome measures ...... ce of primary outcome measure.
@nl
type
label
Contemporary outcome measures ...... ce of primary outcome measure.
@en
Contemporary outcome measures ...... ce of primary outcome measure.
@nl
prefLabel
Contemporary outcome measures ...... ce of primary outcome measure.
@en
Contemporary outcome measures ...... ce of primary outcome measure.
@nl
P2093
P1433
P1476
Contemporary outcome measures ...... ce of primary outcome measure.
@en
P2093
Daniel M Kerr
Danilo Toni
David Matchar
European Stroke Organization Outcomes Working Group
Kennedy R Lees
Peter D Schellinger
Rachael Fulton
Ruchir Sehra
Werner Hacke
P304
P356
10.1161/STROKEAHA.111.641423
P407
P577
2012-03-15T00:00:00Z